Minimally Invasive Therapy & Allied Technologies
ISSN 1364-5706 · Taylor & Francis · United Kingdom · active 1996–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Minimally Invasive Therapy & Allied Technologies a predatory journal?
Our screening does not flag Minimally Invasive Therapy & Allied Technologies. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Minimally Invasive Therapy & Allied Technologies indexed in Scopus or Web of Science?
Per our venue index, Minimally Invasive Therapy & Allied Technologies appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Minimally Invasive Therapy & Allied Technologies?
Papers in Minimally Invasive Therapy & Allied Technologies are cited about 2.9 times each within two years of publication, and Scimago places it in Q2, with an h-index of 60. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Minimally Invasive Therapy & Allied Technologies (Q1, Q2, Q3, or Q4)?
Scimago places Minimally Invasive Therapy & Allied Technologies in Q2 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Minimally Invasive Therapy & Allied Technologies is cited about 2.9 times per paper over two years, with an h-index of 60. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.
What is the Web of Science (JCR) quartile of Minimally Invasive Therapy & Allied Technologies?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Minimally Invasive Therapy & Allied Technologies. The open equivalent is its Scimago quartile, Q2, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Minimally Invasive Therapy & Allied Technologies open access?
We hold no reliable open-access classification for Minimally Invasive Therapy & Allied Technologies. Check the journal's own site for its access model and any article processing charge.